betway必威登陆网址 (betway.com )学报››2022,Vol. 43››Issue (6): 427-434.DOI:10.3969/j.issn.2097-0005.2022.06.005
宋亚光1(), 闫文菊2(
), 姚娜2, 张焕轶2(
), 尹鲁骅2, 周庆秋3, 孙康4
收稿日期:
2022-01-24出版日期:
2022-06-25发布日期:
2022-06-24通讯作者:
张焕轶作者简介:
宋亚光,硕士,讲师,医师,国家高级心理咨询师,研究方向:心血管内科,心理健康教育,E-mail:18263806668@163.com基金资助:
Yaguang SONG1(), Wenju YAN2(
), Na YAO2, Huanyi ZHANG2(
), Luhua YIN2, Qingqiu ZHOU3, Kang SUN4
Received:
2022-01-24Online:
2022-06-25Published:
2022-06-24Contact:
Huanyi ZHANG摘要:
了解急性冠脉综合征(acute coronary syndrome, ACS)患者抑郁程度与冠脉狭窄程度及内皮功能障碍的关系,评价ACS合并抑郁患者的短期预后。
选取确诊为ACS的患者108例。根据抑郁自评量表(self?rating depression scale, SDS)评分(临界值为53分)将入选患者分为无抑郁组和抑郁组。统计冠脉造影结果及Gensini积分。统一检测血清不对称二甲基精氨酸(asymmetric dimethylarginine, ADMA)值。统计出院3个月主要不良心血管事件(因冠心病再次入院、死亡及心肌梗死)的情况。
两组患者在超敏?C反应蛋白、天门冬氨酸氨基转移酶、SDS得分、Gensini积分及血清ADMA水平差异有统计学意义(P< 0.05)。将抑郁组分为轻、中、重度抑郁3个亚组,3个亚组间SDS得分、Gensini积分及ADMA浓度水平差异有统计学意义(P< 0.05)。SDS得分与超敏?C反应蛋白、天门冬氨酸氨基转移酶、Gensini积分、ADMA浓度水平均成正相关。出院后3个月随访结果,显示两组在再次入院、心肌梗死及因冠心病死亡的主要不良心血管事件之间比较,差异无统计学意义(P> 0.05)。3亚组间在出院后3个月在再次入院事件、心肌梗死事件及因冠心病死亡事件的差异均有统计学意义(P< 0.05)。
ACS患者合并抑郁障碍可加重冠脉狭窄程度,且抑郁障碍程度与冠脉狭窄程度呈正相关。ACS患者合并抑郁障碍影响患者内皮功能,且抑郁程度越重,内皮功能损害程度越重。抑郁影响ACS患者短期预后。
宋亚光, 闫文菊, 姚娜, 张焕轶, 尹鲁骅, 周庆秋, 孙康. 急性冠脉综合征患者抑郁程度与冠脉狭窄及内皮功能障碍的关系[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(6): 427-434.
Yaguang SONG, Wenju YAN, Na YAO, Huanyi ZHANG, Luhua YIN, Qingqiu ZHOU, Kang SUN. The relationship between depression, severity of coronary artery lesion and endothelial dysfunction in patients with acute coronary syndrome[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(6): 427-434.
一般资料 | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | t/χ2 | P |
---|---|---|---|---|
年龄(岁) | 59.86 ± 9.89 | 60.24 ± 10.11 | 5.242 | 0.113 |
性别(男/女) | 26/27 | 27/28 | 0.041 | 0.842 |
BMI(kg/m2) | 24.37 ± 0.76 | 24.66 ± 0.80 | 0.298 | 0.732 |
高血压[n(%)] | 20(37.73) | 24(43.64) | 0.182 | 0.671 |
糖尿病[n(%)] | 6(11.32) | 8(14.55) | 0.047 | 0.824 |
家族史[n(%)] | 4(7.55) | 7(12.73) | 0.333 | 0.571 |
吸烟[n(%)] | 16(30.19) | 17(30.91) | 0.022 | 0.892 |
表1无抑郁组和抑郁组一般情况比较
一般资料 | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | t/χ2 | P |
---|---|---|---|---|
年龄(岁) | 59.86 ± 9.89 | 60.24 ± 10.11 | 5.242 | 0.113 |
性别(男/女) | 26/27 | 27/28 | 0.041 | 0.842 |
BMI(kg/m2) | 24.37 ± 0.76 | 24.66 ± 0.80 | 0.298 | 0.732 |
高血压[n(%)] | 20(37.73) | 24(43.64) | 0.182 | 0.671 |
糖尿病[n(%)] | 6(11.32) | 8(14.55) | 0.047 | 0.824 |
家族史[n(%)] | 4(7.55) | 7(12.73) | 0.333 | 0.571 |
吸烟[n(%)] | 16(30.19) | 17(30.91) | 0.022 | 0.892 |
辅助检查 | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | t | P |
---|---|---|---|---|
Hb(g/L) | 136.84 ± 17.43 | 135.62 ± 16.50 | 0.373 | 0.711 |
TC(mmol/L) | 4.15 ± 1.03 | 4.23 ± 1.15 | -0.368 | 0.720 |
TG(mmol/L) | 1.55 ± 1.03 | 1.53 ± 1.89 | 0.081 | 0.932 |
LDL-C(mmol/L) | 2.33 ± 0.72 | 2.59 ± 0.95 | 1.618 | 0.112 |
HDL-C(mmol/L) | 1.27 ± 0.42 | 1.17 ± 0.27 | 1.472 | 0.150 |
Hs-CRP(mg/L) | 4.08 ± 0.60 | 11.74 ± 2.63 | -2.847 | 0.003 |
AST(U/L) | 31.64 ± 38.45 | 55.00 ± 73.18 | -2.092 | 0.041 |
Cr(μmol/L) | 76.94 ± 14.64 | 79.38 ± 22.91 | 1.823 | 0.070 |
LVEF | 0.58 ± 7.16 | 0.62 ± 6.89 | 0.868 | 0.392 |
表2无抑郁组和抑郁组辅助检查结果比较(xˉ± s)
辅助检查 | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | t | P |
---|---|---|---|---|
Hb(g/L) | 136.84 ± 17.43 | 135.62 ± 16.50 | 0.373 | 0.711 |
TC(mmol/L) | 4.15 ± 1.03 | 4.23 ± 1.15 | -0.368 | 0.720 |
TG(mmol/L) | 1.55 ± 1.03 | 1.53 ± 1.89 | 0.081 | 0.932 |
LDL-C(mmol/L) | 2.33 ± 0.72 | 2.59 ± 0.95 | 1.618 | 0.112 |
HDL-C(mmol/L) | 1.27 ± 0.42 | 1.17 ± 0.27 | 1.472 | 0.150 |
Hs-CRP(mg/L) | 4.08 ± 0.60 | 11.74 ± 2.63 | -2.847 | 0.003 |
AST(U/L) | 31.64 ± 38.45 | 55.00 ± 73.18 | -2.092 | 0.041 |
Cr(μmol/L) | 76.94 ± 14.64 | 79.38 ± 22.91 | 1.823 | 0.070 |
LVEF | 0.58 ± 7.16 | 0.62 ± 6.89 | 0.868 | 0.392 |
用药情况 | 无抑郁组(n= 53) | 抑郁组 (n= 55) | χ2 | P |
---|---|---|---|---|
阿司匹林 | 53(100) | 55(100) | ||
氯吡格雷 | 53(100) | 55(100) | ||
他汀类 | 50(94.34) | 53(96.37) | 0.144 | 0.113 |
ACEI或ARB | 30(56.60) | 36(65.45) | 0.562 | 0.450 |
β受体阻滞剂 | 36(67.92) | 42(76.37) | 0.578 | 0.451 |
钙离子拮抗剂 | 15(28.30) | 20(36.37) | 0.483 | 0.492 |
硝酸酯类药物 | 20(37.74) | 28(50.90) | 1.403 | 0.243 |
尼可地尔 | 5(9.43) | 8(14.55) | 0.266 | 0.602 |
Ⅱb/Ⅲa受体拮抗剂 | 7(13.21) | 19(34.55) | 5.608 | 0.010 |
表3无抑郁组和抑郁组用药情况比较[n(%)]
用药情况 | 无抑郁组(n= 53) | 抑郁组 (n= 55) | χ2 | P |
---|---|---|---|---|
阿司匹林 | 53(100) | 55(100) | ||
氯吡格雷 | 53(100) | 55(100) | ||
他汀类 | 50(94.34) | 53(96.37) | 0.144 | 0.113 |
ACEI或ARB | 30(56.60) | 36(65.45) | 0.562 | 0.450 |
β受体阻滞剂 | 36(67.92) | 42(76.37) | 0.578 | 0.451 |
钙离子拮抗剂 | 15(28.30) | 20(36.37) | 0.483 | 0.492 |
硝酸酯类药物 | 20(37.74) | 28(50.90) | 1.403 | 0.243 |
尼可地尔 | 5(9.43) | 8(14.55) | 0.266 | 0.602 |
Ⅱb/Ⅲa受体拮抗剂 | 7(13.21) | 19(34.55) | 5.608 | 0.010 |
指标 | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | t | P |
---|---|---|---|---|
SDS得分 | 35.64 ± 9.15 | 62.46 ± 6.59 | -4.612 | < 0.001 |
Gensini积分 | 22.90 ± 8.64 | 32.62 ± 12.93 | -17.422 | < 0.001 |
ADMA(umol/L) | 5.48 ± 0.98 | 5.83 ± 0.56 | -2.218 | 0.033 |
表4无抑郁组和抑郁组SDS 得分、Gensini积分与ADMA 浓度水平比较
指标 | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | t | P |
---|---|---|---|---|
SDS得分 | 35.64 ± 9.15 | 62.46 ± 6.59 | -4.612 | < 0.001 |
Gensini积分 | 22.90 ± 8.64 | 32.62 ± 12.93 | -17.422 | < 0.001 |
ADMA(umol/L) | 5.48 ± 0.98 | 5.83 ± 0.56 | -2.218 | 0.033 |
指标 | 轻度抑郁(n= 32) | 中度抑郁(n= 15) | 重度抑郁(n= 8) | F | P |
---|---|---|---|---|---|
SDS得分 | 57.70 ± 2.45 | 67.67 ± 2.72 | 73.71 ± 0.95 | 173.647 | < 0.001 |
Gensini积分 | 25.49 ± 10.94 | 41.53 ± 7.51 | 47.14 ± 3.33 | 24.132 | < 0.001 |
ADMA(umol/L) | 5.58 ± 0.46 | 6.06 ± 0.28 | 6.49 ± 0.72 | 14.053 | < 0.001 |
表5轻、中、重度抑郁患者SDS 得分、Gensini积分与ADMA 浓度水平比较(xˉ± s)
指标 | 轻度抑郁(n= 32) | 中度抑郁(n= 15) | 重度抑郁(n= 8) | F | P |
---|---|---|---|---|---|
SDS得分 | 57.70 ± 2.45 | 67.67 ± 2.72 | 73.71 ± 0.95 | 173.647 | < 0.001 |
Gensini积分 | 25.49 ± 10.94 | 41.53 ± 7.51 | 47.14 ± 3.33 | 24.132 | < 0.001 |
ADMA(umol/L) | 5.58 ± 0.46 | 6.06 ± 0.28 | 6.49 ± 0.72 | 14.053 | < 0.001 |
病变部位 | 轻度抑郁(n= 32) | 中度抑郁(n= 15) | 重度抑郁(n= 8) | χ2 | P |
---|---|---|---|---|---|
单支病变 | 15(46.88) | 6(40.00) | 2(25.00) | 1.289 | 0.532 |
双支病变 | 11(34.38) | 7(46.67) | 3(37.50) | 0.661 | 0.720 |
多支病变 | 6(18.75) | 2(13.33) | 3(37.50) | 1.977 | 0.371 |
LM | 1(3.13) | 0(0) | 1(12.50) | 2.872 | 0.243 |
LAD | 22(68.75) | 10(66.67) | 5(62.50) | 0.063 | 0.972 |
LCX | 12(37.50) | 6(40.00) | 3(37.50) | 0.129 | 0.941 |
RCA | 12(37.50) | 5(33.33) | 3(37.50) | 0.187 | 0.912 |
表6轻、中、重度抑郁患者冠脉造影相关情况比较[n(%)]
病变部位 | 轻度抑郁(n= 32) | 中度抑郁(n= 15) | 重度抑郁(n= 8) | χ2 | P |
---|---|---|---|---|---|
单支病变 | 15(46.88) | 6(40.00) | 2(25.00) | 1.289 | 0.532 |
双支病变 | 11(34.38) | 7(46.67) | 3(37.50) | 0.661 | 0.720 |
多支病变 | 6(18.75) | 2(13.33) | 3(37.50) | 1.977 | 0.371 |
LM | 1(3.13) | 0(0) | 1(12.50) | 2.872 | 0.243 |
LAD | 22(68.75) | 10(66.67) | 5(62.50) | 0.063 | 0.972 |
LCX | 12(37.50) | 6(40.00) | 3(37.50) | 0.129 | 0.941 |
RCA | 12(37.50) | 5(33.33) | 3(37.50) | 0.187 | 0.912 |
统计量 | 年龄 | BMI | TC | LDL‑C | Hs‑CRP | AST | Gensini积分 | ADMA |
---|---|---|---|---|---|---|---|---|
r | -0.021 | -0.111 | -0.018 | 0.092 | 0.158 | 0.201 | 0.488 | 0.232 |
P | 0.878 | 0.343 | 0.872 | 0.379 | 0.042 | 0.042 | < 0.001 | 0.020 |
表7SDS得分的相关因素分析(r为相关系数)
统计量 | 年龄 | BMI | TC | LDL‑C | Hs‑CRP | AST | Gensini积分 | ADMA |
---|---|---|---|---|---|---|---|---|
r | -0.021 | -0.111 | -0.018 | 0.092 | 0.158 | 0.201 | 0.488 | 0.232 |
P | 0.878 | 0.343 | 0.872 | 0.379 | 0.042 | 0.042 | < 0.001 | 0.020 |
MACEs | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | χ2 | P |
---|---|---|---|---|
再次住院 | 1(1.89) | 6(10.90) | 2.292 | 0.132 |
心肌梗死 | 1(1.89) | 3(5.45) | 0.218 | 0.641 |
死亡 | 0(0) | 1(1.82) | 0 | > 0.999 |
表8无抑郁组与抑郁组患者出院后MACEs的比较[n(%)]
MACEs | 无抑郁组 (n= 53) | 抑郁组 (n= 55) | χ2 | P |
---|---|---|---|---|
再次住院 | 1(1.89) | 6(10.90) | 2.292 | 0.132 |
心肌梗死 | 1(1.89) | 3(5.45) | 0.218 | 0.641 |
死亡 | 0(0) | 1(1.82) | 0 | > 0.999 |
MACEs | 轻度抑郁(n= 32) | 中度抑郁(n= 15) | 重度抑郁(n= 8) | χ2 | P |
---|---|---|---|---|---|
再次住院 | 1(3.13) | 2(13.33) | 3(37.50) | 7.912 | 0.022 |
心肌梗死 | 0(0) | 1(6.67) | 2(25.00) | 7.819 | 0.020 |
死亡 | 0(0) | 0(0) | 1(12.50) | 6.977 | 0.031 |
表9轻、中、重度抑郁患者出院后MACEs的比较[n(%)]
MACEs | 轻度抑郁(n= 32) | 中度抑郁(n= 15) | 重度抑郁(n= 8) | χ2 | P |
---|---|---|---|---|---|
再次住院 | 1(3.13) | 2(13.33) | 3(37.50) | 7.912 | 0.022 |
心肌梗死 | 0(0) | 1(6.67) | 2(25.00) | 7.819 | 0.020 |
死亡 | 0(0) | 0(0) | 1(12.50) | 6.977 | 0.031 |
1 | Janszky I, Ahnve S, Lundberg I, et al. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men[J]. J Am Coll Cardiol, 2010, 56(1): 31. |
2 | Meijer A, Conradi HJ, Bos EH, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis[J]. Br J Psychiatry, 2013, 203(2): 90. |
3 | Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993, 362(6423): 801. |
4 | Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure[J]. Lancet, 1992, 339(8793): 572. |
5 | Elesber AA, Solomon H, Lennon RJ, et al. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis[J]. Eur Heart J, 2006, 27(7): 824. |
6 | Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease[J]. Am J Cardiol, 1996, 78(6): 613. |
7 | 朱涛, 孙晓斐, 徐勤成, 等. 抑郁与冠状动脉病变特点的相关性[J]. 心脏杂志, 2016, 28(3): 305. |
8 | Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart disease[J]. Neurosci Biobehav Rev, 2002, 26(8): 941. |
9 | Carney RM, Freedland KE. Depression and heart rate variability in patients with coronary heart disease[J]. Cleve Clin J Med, 2009, 76(): S13. |
10 | Tousoulis D, Antoniades C, Koumallos N, et al. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside[J]. Cytokine Growth Factor Rev, 2006, 17(4): 225. |
11 | Sukhija R, Fahdi I, Garza L, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome[J]. Am J Cardiol, 2007, 99(7): 879. |
12 | Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis[J]. Psychosom Med, 2009, 71(2): 171. |
13 | Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression[J]. Biol Psychiatry, 2009, 65(9): 732. |
14 | Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain[J]. Nat Rev Neurosci, 2008, 9(1): 46. |
15 | Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study[J]. J Am Coll Cardiol, 2007, 50(21): 2044. |
16 | 杨超君, 杨俊. 冠心病的早期干预及抗血小板、抗凝治疗新进展[J]. 中国老年学杂志, 2014, 34(18): 5292. |
17 | 田新利, 李俊峡. 血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在非ST段抬高急性冠脉综合征中的规范应用[J]. 中国临床医生, 2014, 42(9): 6. |
18 | Von Känel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?[J]. Acta Psychiatr Scand, 2004, 110(3): 163. |
19 | Wulsin LR, Musselman D, Otte C, et al. Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study[J]. Psychosom Med, 2009, 71(3): 260. |
20 | Nijm J, Jonasson L. Inflammation and cortisol response in coronary artery disease[J]. Ann Med, 2009, 41(3): 224. |
21 | Coleman LS. A stress repair mechanism that maintains vertebrate structure during stress[J]. Cardiovasc Hematol Disord Drug Targets, 2010, 10(2): 111. |
22 | Tanaka Y, Ishitobi Y, Maruyama Y, et al. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 36(2): 220. |
23 | Licht CM, Vreeburg SA, Van Reedt Dortland AK, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities[J]. J Clin Endocrinol Metab, 2010, 95(5): 2458. |
24 | Watts SW. 5-HT in systemic hypertension: foe, friend or fantasy?[J]. Clin Sci (Lond), 2005, 108(5): 399. |
25 | Lundberg AK, Lundgren O, Jonasson L. Cytokines and depressive mood in coronary artery disease[J]. Atherosclerosis, 2014, 235(2): e141. |
26 | Cates LN, Roberts AJ, Huitron-Resendiz S, et al. Effects of lurasidone in behavioral models of depression. Role of the 5-HT7receptor subtype[J]. Neuropharmacology, 2013, 70: 211. |
27 | McAllister-Williams RH. S.03.03 5-HT1A receptors in depressed patients: Evidence from PET,post mortemand EEG based studies[J]. Eur Neuropsychopharmacol, 2014, 24(Suppl-2): S113. |
28 | 崔青扬, 丁建东, 李浩, 等. 5-羟色胺转运体基因多态性与冠心病合并抑郁相关性的 Meta 分析[J]. 东南大学学报(医学版), 2015, 34(5): 792. |
29 | Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor[J]. Cardiovasc Res, 2003, 59(4): 824. |
30 | Sonmez A, Celebi G, Erdem G, et al. Plasma apelin and ADMA Levels in patients with essential hypertension[J]. Clin Exp Hypertens, 2010, 32(3): 179. |
31 | Richir MC, Van Lambalgen AA, Teerlink T, et al. Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model[J]. Crit Care Med, 2009, 37(6): 2010. |
32 | YU Xl, LIU Y. The effect to asymmetric dimethylarginine and C-reactive protein of Atherosclerosis rabbits dyslipidemia[J]. Shandong Medical J, 2010, 50(33): 28. |
33 | Riccioni G, Bucciarelli V, Scotti L, et al. Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis[J]. J Biol Regul Homeost Agents, 2010, 24(3): 351. |
34 | 莫与京, 陈富荣, 陈东骊. 高血压患者血清尿酸与ADMA的关系[J]. 实用医学杂志, 2009, 25(18): 3039. |
35 | Sertkaya AC, Kafkasli A, Turkcuoglu I, et al. Asymmetric dimethylarginine level in hyperglycemic gestation[J]. Endocrine, 2011, 40(2): 237. |
36 | Summers KM, Martin KE, Watson K. Impact and clinical management of depression in patients with coronary artery disease[J]. Pharmacotherapy, 2010, 30(3): 304. |
37 | De Jonge P, Rosmalen JG, Kema IP, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature[J]. Neurosci Biobehav Rev, 2010, 35(1): 84. |
38 | Serrano CVJ, Setani KT, Sakamoto E, et al. Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications[J]. Vasc Health Risk Manag, 2011, 7: 159. |
39 | Van Dijk MR, Utens EM, Dulfer K, et al. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up[J]. Eur J Prev Cardiol, 2016, 23(5): 552. |
40 | 胡大一, 丁荣晶. 关注心血管疾病患者精神心理卫生的建议[J]. 中华心血管病杂志, 2012, 40(2): 89-91. |
[1] | 郭浩阳, 汪伟, 季新灿, 陶梦君, 袁慧.1990—2019年中国抑郁症发病趋势的Joinpoint回归与年龄‐时期‐队列分析[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(6): 430-436. |
[2] | 陈世才, 张婷, 张汉霆, 张芳芳.磷酸二酯酶在慢性疼痛与抑郁共病中的作用[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(4): 260-263. |
[3] | 王丽, 常想想, 吴佩林, 郭伟, 张雁群, 王丽, 王丽丹.安徽省农村老年人抑郁倾向与认知功能障碍风险[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(3): 224-229. |
[4] | 张萌, 高传丽, 张冉冉, 崔媛媛, 冯慧娜, 张艳美, 苏静.代际支持对老年人抑郁、孤独感和主观幸福感的影响[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(6): 416-421. |
[5] | 李慧慧, 刘蕴玲.老年T2DM合并高血压患者血清25(OH)D水平与抑郁情绪关系[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(5): 353-359. |
[6] | 薛娇美, 苏静, 林萍珍.自助心理干预对老年人抑郁情绪治疗效果的Meta分析[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(3): 187-192. |
[7] | 李淑君, 陈登攀, 孙悦东, 周新玲, 高云, 周发展.MPVLR联合hs-CRP对PCI术后对比剂肾病的预测价值[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(12): 924-931. |
[8] | 孙子雯, 张耘硕, 曹盛楠, 马帅, 孙国栋.颈椎病脑-交感神经症状产生机制[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(11): 876-880. |
[9] | 孙菲菲, 李军, 胡传芬, 张伯全, 王爱青, 王芳, 赵海英.抑郁症患者舞动治疗体验的质性研究[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(11): 829-833. |
[10] | 焦敏, 苗帅, 徐晓燕.乌灵胶囊联合黛力新治疗脑卒中后抑郁有效性和安全性的Meta分析[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(9): 685-690. |
[11] | 王婷, 吕珂, 周方方.分析高龄产妇产后抑郁症与人格特征的相关性[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(6): 430-432. |
[12] | 苗帅, 焦敏, 徐晓燕.舒肝解郁胶囊联合艾司西酞普兰治疗抑郁症的Meta分析[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(5): 390-395. |
[13] | 朱婷, 沈兴蓉, 刘荣, 江健健, 王德斌.安徽省部分农村地区高血压患者血压、抑郁及血压控制行为关系[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(11): 864-870. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||